Alpha Compute Corp. (ALP)
3.02
+0.05
(+1.68%)
USD |
NASDAQ |
Oct 23, 16:00
3.00
-0.02
(-0.66%)
Pre-Market: 20:00
Alpha Compute Net Income (Quarterly)
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2025 | -10.37M |
| June 30, 2025 | |
| March 31, 2025 | |
| December 31, 2024 | |
| September 30, 2024 | -1.362M |
| June 30, 2024 | -1.664M |
| March 31, 2024 | -24.91M |
| December 31, 2023 | -39.38M |
| September 30, 2023 | -5.165M |
| June 30, 2023 | -5.926M |
| March 31, 2023 | -94.46M |
| December 31, 2022 | -7.501M |
| September 30, 2022 | -1.085M |
| June 30, 2022 | -1.625M |
| March 31, 2022 | -8.863M |
| December 31, 2021 | -4.206M |
| September 30, 2021 | -2.877M |
| June 30, 2021 | -3.223M |
| March 31, 2021 | -12.50M |
| December 31, 2020 | -1.35M |
| September 30, 2020 | -2.689M |
| June 30, 2020 | -0.655M |
| March 31, 2020 | -1.886M |
| December 31, 2019 | -1.726M |
| September 30, 2019 | -1.701M |
| Date | Value |
|---|---|
| June 30, 2019 | -1.936M |
| March 31, 2019 | -2.874M |
| December 31, 2018 | -0.292M |
| September 30, 2018 | -0.209M |
| June 30, 2018 | -0.219M |
| March 31, 2018 | 124.77M |
| December 31, 2017 | -0.351M |
| September 30, 2017 | -0.341M |
| June 30, 2017 | -0.333M |
| March 31, 2017 | -23.35M |
| December 31, 2016 | -6.073M |
| September 30, 2016 | 33.86M |
| June 30, 2016 | -5.076M |
| March 31, 2016 | -1.792M |
| December 31, 2015 | -4.833M |
| September 30, 2015 | -1.534M |
| June 30, 2015 | -1.036M |
| March 31, 2015 | -1.445M |
| December 31, 2014 | -0.8889M |
| September 30, 2014 | -0.9738M |
| June 30, 2014 | -1.034M |
| March 31, 2014 | -1.988M |
| December 31, 2013 | -0.2922M |
| September 30, 2013 | -0.3483M |
| June 30, 2013 | -3.998M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Agenus, Inc. | -0.567M |
| Amgen, Inc. | 2.375B |
| Anika Therapeutics, Inc. | 3.309M |
| BioCryst Pharmaceuticals, Inc. | 78.40M |
| Compugen Ltd. | -7.006M |
Net Income (Quarterly) Related Metrics
| Enterprise Value | 70.00M |
| Earnings Yield | -136.9% |